When did ITERUM THERAPEUTICS PLC (ITRM) report earnings last quarter?
ITERUM THERAPEUTICS PLC (ITRM) last reported earnings on 3/12/2026.
ITERUM THERAPEUTICS PLC (ITRM) Earnings History & Surprises
NASDAQ:ITRM • IE000TTOOBX0
Current stock price
0.1715 USD
+0 (+0.29%)
At close:
0.1738 USD
+0 (+1.34%)
Pre-Market:
ITRM Earnings overview
Past quarterly earnings results for ITERUM THERAPEUTICS PLC (ITRM), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.15
- Revenue Estimate
- 515.1K
Last Reported
Most Recent- Release Date
- Mar 12, 2026
- Period
- Q3 / 2025
- EPS Reported
- -$0.20
- EPS Surprise
- -78.25%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 25%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.20 | -0.11 | -78.25% | 33.33% | 390K | - | - | |
| Q2 2025 | -0.16 | -0.11 | -42.60% | 46.67% | - | - | ||
| Q1 2025 | -0.14 | -0.15 | 5.34% | 69.57% | 2.737M | -100.00% | - | |
| Q4 2024 | -0.23 | -0.22 | -4.88% | 75.53% | - | - | ||
| Q3 2024 | -0.30 | -0.20 | -47.06% | - | - | - | ||
| Q2 2024 | -0.30 | -0.46 | 34.64% | 68.42% | - | - | ||
| Q1 2024 | -0.46 | -0.74 | 37.80% | 62.42% | - | - | ||
| Q4 2023 | -0.94 | -0.95 | 1.44% | -129.27% | - | - | ||
| Q3 2023 | -0.30 | -0.93 | 67.68% | 69.07% | - | - | ||
| Q2 2023 | -0.95 | -1.22 | 22.39% | -58.33% | - | - | ||
| Q1 2023 | -1.22 | - | -308.00% | - | - | |||
| Q4 2022 | -0.41 | -1.22 | 66.50% | -36.67% | - | - | ||
| Q3 2022 | -0.97 | -1.07 | 9.43% | -423.33% | - | - | ||
| Q2 2022 | -0.60 | -1.07 | 43.98% | -200.00% | - | - | ||
| Q1 2022 | -0.30 | -0.77 | 60.78% | 97.53% | - | - | ||
| Q4 2021 | -0.30 | -0.61 | 50.98% | 92.59% | - | - | ||
| Q3 2021 | 0.30 | 1.84 | -83.66% | 103.33% | - | - | ||
| Q2 2021 | 0.60 | -0.99 | 160.33% | 105.00% | - | - | ||
| Q1 2021 | -12.15 | -1.07 | -1,034.45% | 10.00% | - | - | ||
| Q4 2020 | -4.05 | -2.96 | -36.92% | - | - | - | ||
| Q3 2020 | -9.00 | -7.85 | -14.59% | - | - | - | ||
| Q2 2020 | -12.00 | -12.39 | 3.17% | - | - | - | ||
| Q1 2020 | -13.50 | -20.46 | 34.03% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-30.10%
Max EPS beat (4)
5.34%
Min EPS beat (4)
-78.25%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, ITRM has beaten EPS estimates in 1 out of 4 releases
In the last 4 quarters, ITRM reported -30.1% below the EPS estimates on average.
Related analysis
ITERUM THERAPEUTICS PLC / ITRM Earnings FAQ
Did ITRM stock beat earnings estimates in the most recent quarter?
ITERUM THERAPEUTICS PLC (ITRM) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does ITRM stock beat earnings estimates?
In the last 4 quarters, ITERUM THERAPEUTICS PLC (ITRM) has beaten EPS estimates in 1 out of 4 releases.